Commission Delegated Regulation (EU) 2018/772Show full title

Article 6 U.K. Preventive health measures

1. The owner or authorised person as defined in points (c) and (d) of Article 3 of Regulation (EU) No 576/2013 shall ensure that dogs moved into [F1 Great Britain] have undergone a treatment against mature and immature intestinal forms of the Echinococcus multilocularis parasite.

2. The treatment referred to in paragraph 1 shall be carried out within a period of not more than 120 hours and not less than 24 hours before the time of the dog's scheduled entry into [F2 Great Britain] in accordance with paragraphs 3 and 4 of this Article.

3. The treatment referred to in paragraph 1 shall be administered by a veterinarian and shall consist of a medicinal product:

(a) which contains the appropriate dose of:

(i)

praziquantel, or

(ii)

other pharmacologically active substances, which alone or in combination, have been proven to reduce the burden of mature and immature intestinal forms of the Echinococcus multilocularis parasite in dogs at least as effectively as praziquantel; and

(b) which has been granted:

(i)

a marketing authorisation in accordance with [F3 regulation 4 of the Veterinary Medicines Regulations 2013] or Article 3 of Regulation (EC) No 726/2004 of the European Parliament and of the Council(1) [F4 as it has effect in European Union law, as amended from time to time], or

(ii)

an approval or a licence by the competent authority of the third country of dispatch of the dog intended for non-commercial movement.

[F5 4. The treatment referred to in paragraph 1 must be certified in the relevant section of the identification document by:

(a) where paragraph 4A applies, the administering veterinarian;

(b) where paragraph 4B applies—

(i) an official veterinarian of the third country of departure; or

(ii) an authorised veterinarian, provided an official veterinarian of the third country of departure subsequently endorses the certification.

4A. This paragraph applies in the case of non-commercial movements of dogs into Great Britain from a third country listed in Part 1 of Annex 2 to the Commission Implementing Regulation, after movement to or transit through a third country which is not so listed.

4B. This paragraph applies in the case of non-commercial movements of dogs into Great Britain from a third country not listed in Part 1 of Annex 2 to the Commission Implementing Regulation.]

Textual Amendments

F1 Words in Art. 6(1) substituted (E.W.S.) (31.12.2020) by The Animals, Aquatic Animal Health, Invasive Alien Species, Plant Propagating Material and Seeds (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1388), regs. 1(2)(c), 17(5)(a)

F2 Words in Art. 6(2) substituted (E.W.S.) (31.12.2020) by The Animals, Aquatic Animal Health, Invasive Alien Species, Plant Propagating Material and Seeds (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1388), regs. 1(2)(c), 17(5)(b)

F3 Words in Art. 6(3)(b)(i) substituted (E.W.S.) (31.12.2020) by The Animals, Aquatic Animal Health, Invasive Alien Species, Plant Propagating Material and Seeds (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1388), regs. 1(2)(c), 17(5)(c)(i)

F4 Words in Art. 6(3)(b)(i) inserted (E.W.S.) (31.12.2020) by The Animals, Aquatic Animal Health, Invasive Alien Species, Plant Propagating Material and Seeds (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1388), regs. 1(2)(c), 17(5)(c)(ii)

F5 Art. 6(4)-(4B) substituted for Art. 6(4) (E.W.S.) (31.12.2020) by The Animals, Aquatic Animal Health, Invasive Alien Species, Plant Propagating Material and Seeds (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1388), regs. 1(2)(c), 17(5)(d)

(1)

Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (OJ L 136, 30.4.2004, p. 1).